Suppr超能文献

COVID-19 后同种异体肾移植:病例报告。

Allogeneic Kidney Transplantation After COVID-19: A Case Report.

机构信息

Department of Urology and Transplant Surgery, Toda Chuo General Hospital, Saitama, Japan.

Department of Urology and Transplant Surgery, Toda Chuo General Hospital, Saitama, Japan.

出版信息

Transplant Proc. 2022 Jul-Aug;54(6):1551-1553. doi: 10.1016/j.transproceed.2021.10.004. Epub 2021 Oct 15.

Abstract

BACKGROUND

Patients undergoing organ transplantation are immunosuppressed and already at risk of various diseases. We report about a patient who underwent ABO-incompatible kidney transplantation after coronavirus disease 2019 (COVID-19) without a recurrence of infection.

CASE REPORT

A 68-year-old woman presented with end-stage renal failure owing to primary autosomal dominant polycystic kidney disease; accordingly, hemodialysis was initiated in September 2020. Her medical history included bilateral osteoarthritis, lumbar spinal stenosis, hypertension, and hyperuricemia. In mid-January 2021, she contracted severe acute respiratory syndrome coronavirus 2 infection from her husband. Both of them were hospitalized and received conservative treatment. Because their symptoms were mild, they were discharged after 10 days. The patient subsequently underwent ABO-incompatible kidney transplantation from her husband who recovered from COVID-19 in March 2021. Before kidney transplantation, her COVID-19 polymerase chain reaction test was negative, confirming the absence of pre-existing COVID-19 immediately before the procedure. Computed tomography revealed no pneumonia. Initial immunosuppression was induced by administering tacrolimus, mycophenolate mofetil, methylprednisolone, basiliximab, rituximab, and 30 g of intravenous immunoglobulin. Double-filtration plasmapheresis and plasma exchange were performed once before ABO-incompatible kidney transplantation. The renal allograft functioned immediately, and the postoperative course was normal without rejection. COVID-19 did not recur. In addition, her serum creatinine levels and renal function had otherwise remained stable.

CONCLUSION

Living kidney transplantation was safely performed in a patient with COVID-19 without postoperative complications or rejection. During the COVID-19 pandemic, the possibility of severe acute respiratory syndrome coronavirus 2 infection during transplantation surgery must be considered.

摘要

背景

接受器官移植的患者会接受免疫抑制治疗,且已经面临多种疾病的风险。我们报告了一例在感染新型冠状病毒病 2019(COVID-19)后未复发感染的情况下接受 ABO 血型不合肾移植的患者。

病例报告

一名 68 岁女性因常染色体显性多囊肾病导致终末期肾病,因此于 2020 年 9 月开始血液透析。其既往病史包括双侧骨关节炎、腰椎椎管狭窄症、高血压和高尿酸血症。2021 年 1 月中旬,她从丈夫那里感染了严重急性呼吸综合征冠状病毒 2。他们都住院并接受了保守治疗。由于症状轻微,他们在 10 天后出院。此后,患者于 2021 年 3 月从已从 COVID-19 中康复的丈夫那里接受了 ABO 血型不合的肾移植。在肾移植前,她的 COVID-19 聚合酶链反应检测结果为阴性,证实了在手术前没有 COVID-19 既往感染。计算机断层扫描显示没有肺炎。初始免疫抑制通过给予他克莫司、霉酚酸酯、甲基强的松龙、巴利昔单抗、利妥昔单抗和 30g 静脉注射免疫球蛋白来诱导。在 ABO 血型不合肾移植前进行了一次双重滤过血浆置换和血浆交换。移植后肾移植功能立即恢复,术后过程正常,无排斥反应。COVID-19 未复发。此外,她的血清肌酐水平和肾功能一直保持稳定。

结论

在没有术后并发症或排斥反应的情况下,对 COVID-19 患者成功进行了活体肾移植。在 COVID-19 大流行期间,必须考虑移植手术过程中感染严重急性呼吸综合征冠状病毒 2 的可能性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a8a/8516720/7ae4940df838/gr1_lrg.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验